News list for "bio"
Tether is backing the development of a new type of industrial humanoid robot that will take on dangerous and physically demanding jobs in factories and logistics centers. The stablecoin issuer, along with AMD Ventures, Italy's state-backed artificial intelligence fund, and other investors, raised 70 million euros for Generative Bionics, a new spin-off from the Italian Institute of Technology. The year-old company is developing "physical...
Tether公司正在支持一种新型工业人形机器人的研发，这种机器人将承担工厂和物流中心内危险且体力消耗巨大的工作。这家稳定币发行商与AMD Ventures、意大利国家支持的人工智能基金以及其他投资者一起，为Generative Bionics（意大利理工学院的一家新衍生公司）进行了7000万欧元的融资。 这家成立仅一年的公司正在开发“物理...
On November 20th, according to the announcement of Bio Protocol, the second season of BioXP has been launched. Users need to pledge BIO to generate veBIO to obtain ecological token pledge XP and airdrop qualifications. The new mechanisms include: 1) veBIO level multiplier, up to 10 times XP revenue; 2) Pledge 60 days before the new token to enjoy XP bonus; 3) VeBIO holders will automatically receive the new eco-token airdrop. All old BioXPs will expire after the second ignition sale.
11 月 20 日消息，据 Bio Protocol 公告，BioXP 第二季已上线，用户需质押 BIO 生成 veBIO 以获取生态代币质押 XP 与空投资格。新机制包括： 1）veBIO 等级乘数，最高可达 10 倍 XP 收益； 2）新代币前 60 天质押享 XP 加成； 3）VeBIO 持有者将自动接收新生态代币空投。 所有旧 BioXP 将在第二次点火销售后过期。
Quantum BioPharma (NASDAQ: QNTM) today announced financial results for the third quarter of 2025, showing a significant strengthening of the company's finances, with a 275% sequential increase in shareholders' equity, a 50% reduction in total liabilities, and an 87% decrease in debt-to-equity ratio. The company's digital asset portfolio, primarily bitcoin, has realized $572,000 in gains, and total digital assets have increased from $800,000 at the end of 2024 to $5.20 million today.
Quantum BioPharma（纳斯达克股票代码：QNTM）今日公布2025年第三季度财务业绩，显示公司财务状况显著增强，股东权益环比增长275%，总负债减少50%，债务权益比率下降87%。公司数字资产组合（主要为比特币）已实现57.2万美元收益，数字资产总额从2024年底的80万美元增至当前520万美元。
On November 4th, according to Globenewswire, digital asset finance company Propanc Biopharma (NASDAQ: PPCB) announced a strategic plan to acquire digital asset management (DAT) companies that are currently trading below their market capitalization-to-net asset value (MNAV) ratios. Company management believes that the acquisition of undervalued digital asset technology (DAT) companies is a way to strengthen Propanc's balance sheet, diversify its assets and create long-term stocks...
11月4日消息，据Globenewswire报道，数字资产财务公司Propanc Biopharma（纳斯达克股票代码：PPCB）宣布了一项战略计划，旨在收购目前市值与净资产值之比（MNAV）低于其交易的数字资产管理（DAT）公司。公司管理层认为，收购被低估的数字资产技术（DAT）公司是增强Propanc资产负债表、实现资产多元化并创造长期股...
New York-based startup Valthos is developing AI systems to identify and counter biological threats before they spread.
On October 15th, Propanc Biopharma, a biopharmaceutical company that adopts the Ethereum treasury strategy, announced a strategic financing agreement of up to $100 million with the family office Hexstone Capital. Propanc CEO James Nathanielsz said that the financing will accelerate the development of the company's clinical pipeline and plans to grow the value of the digital asset library to $100 million or more in the next 12 months. Hexstone Capital has previously invested in several companies ...
